161 related articles for article (PubMed ID: 19098936)
1. PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.
Wang WM; Zhang HD; Jin YM; Zhu BB; Chen N
Acta Pharmacol Sin; 2009 Jan; 30(1):107-12. PubMed ID: 19098936
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
4. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Wang WM; Liu F; Chen N
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
[TBL] [Abstract][Full Text] [Related]
5. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells].
Song Y; Lin Q; Zheng J; Zhu X; Yang S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
Li X; Kimura H; Hirota K; Sugimoto H; Kimura N; Takahashi N; Fujii H; Yoshida H
Nephrol Dial Transplant; 2007 Apr; 22(4):1041-51. PubMed ID: 17255125
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism underlying the inhibitory effects of peroxisome proliferator-activated receptor γ agonists on transforming growth factor β1 in adult skin fibroblasts].
Yang CZ; Zhang HT; Wang GS; Zhou HQ; Ma C; Hu DH
Zhonghua Shao Shang Za Zhi; 2010 Dec; 26(6):448-51. PubMed ID: 21223655
[TBL] [Abstract][Full Text] [Related]
10. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
Kimura H; Li X; Torii K; Okada T; Takahashi N; Fujii H; Ishihara S; Yoshida H
Nephrol Dial Transplant; 2008 Aug; 23(8):2496-503. PubMed ID: 18367541
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis.
Zhao M; Chen Y; Ding G; Xu Y; Bai M; Zhang Y; Jia Z; Huang S; Zhang A
Oncotarget; 2016 Oct; 7(40):64690-64701. PubMed ID: 27602490
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Nie M; Corbett L; Knox AJ; Pang L
J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells.
Chen Y; Luo Q; Xiong Z; Liang W; Chen L; Xiong Z
Int J Clin Exp Pathol; 2012; 5(6):522-9. PubMed ID: 22949934
[TBL] [Abstract][Full Text] [Related]
16. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.
Kawai T; Masaki T; Doi S; Arakawa T; Yokoyama Y; Doi T; Kohno N; Yorioka N
Lab Invest; 2009 Jan; 89(1):47-58. PubMed ID: 19002105
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
Wang W; Liu F; Chen N
Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
[TBL] [Abstract][Full Text] [Related]
18. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
Yu JH; Kim KH; Kim H
Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
[TBL] [Abstract][Full Text] [Related]
19. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
